Benzathine penicillin G: A documentably important antibiotic in need of a tune-up?

Pediatric Infectious Disease Journal

Volumn 31, Issue 7, 2012, Pages 726-728

  Kaplan, Edward L ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MMC 296 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATHINE PENICILLIN; PENICILLIN G; SULFADIAZINE;

ANAPHYLAXIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; EDITORIAL; ERADICATION THERAPY; GROUP A STREPTOCOCCAL INFECTION; HUMAN; INFECTION CONTROL; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SINGLE DRUG DOSE; SYPHILIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; HUMANS; PENICILLIN G BENZATHINE;

EID: 84862747374     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318259b75c     Document Type: Editorial

References (17)

1. Stollerman GH, Rusoff JH. Prophylaxis against group A streptococcal infections in rheumatic fever patients; use of new repository penicillin preparation. J Am Med Assoc. 1952;150:1571-1575.
2. Wood HF, Feinstein AR, Taranta A, Epstein JA, Simpson R. Rheumatic fever in children and adolescents. III. Comparative effectiveness of three prophylaxis regimens in preventing streptococcal infections and rheumatic recurrences. Ann Intern Med. 1964;60 (suppl 5):31-36.
3. Strasser T, Dondog N, El Kholy A, et al. The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project. Bull World Health Organ. 1981;59:285-294. (Pubitemid 11035761)
4. Broderick MP, Hansen CJ, Faix DJ. Factors associated with loss of penicillin G concentrations in serum after intramuscular benzathine penicillin G injection: a meta-analysis. Pediatr Infect Dis J. 2012;31:722-725.
5. United States Centers for Disease Control. Available at: http://www.cdc.gov/std/treatment/2010/genital-ulcers.htm#syphilis. Accessed March 27, 2012.
6. Broderick MP, Hansen CJ, Russell KL, Kaplan EL, Blumer JL, Faix DJ. Serum penicillin G levels are lower than expected in adults within two weeks of administration of 1.2 million units. PLoS ONE. 2011;10:1-6.
7. Kaplan EL, Johnson DR. Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group a streptococci from children with acute pharyngitis. Pediatrics. 2001;108:1180-1186. (Pubitemid 33021196)
8. Lue HC, Wu MH, Wang JK, et al. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks. J Pediatr. 1994;125(5 pt 1):812-816.
9. Zaher SR, Kassem AS, Abou-Shleib H, El-Kholy AG, Madkour AA, Kaplan EL. Differences in serum penicillin concentrations following intramuscular injection of benzathine penicillin G (BPG) from different manufacturers. J Pharm Med. 1992;2:17-23.
10. Kaplan EL. The group A streptococcal upper respiratory tract carrier state: an enigma. J Pediatr. 1980;97:337-345. (Pubitemid 11225833)
11. Kaplan EL, Chhatwal GS, Rohde M. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis. 2006;43:1398-1406. (Pubitemid 44845639)
12. Markowitz M, Kaplan EL, Cuttica R, et al. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet. 1991;337:1308-1310.
13. Currie BJ, Burt T, Kaplan EL. Penicillin concentrations after increased doses of benzathine penicillin G for prevention of secondary rheumatic fever. Antimicrob Agents Chemother. 1994;38:1203-1204. (Pubitemid 24150869)
14. Lin S, Kaplan EL, Rao X, et al. A school-based program for control of group a streptococcal upper respiratory tract infections: a controlled trial in Southern China. Pediatr Infect Dis J. 2008;27:753-755.
15. Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med. 1987;316:421-427. (Pubitemid 17035568)
16. Kaplan EL. T. Duckett Jones Memorial Lecture. Global assessment of rheumatic fever and rheumatic heart disease at the close of the century. Influences and dynamics of populations and pathogens: a failure to realize prevention? Circulation. 1993;88(4 pt 1):1964-1972.
17. Carapetis JR, Steer AC, Mulholland EK, et al. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5:685-694. (Pubitemid 41505357)